Skip to the content
Know your tech before you buy it. Makers: get listed from $49/mo

C4X Discovery Taxonomy3

c4xdiscovery.com

5.3 Club score Visit c4xdiscovery.com

What the maker publishes

Clinical-trial application
PatientSeek is described as supporting clinical-trial design and companion diagnostics. source
Collaboration
C4X Discovery describes a Taxonomy3 collaboration with the GEN-COVID Consortium in Italy to examine COVID-19 genetics. source
Commercial model
C4X Discovery says its business model includes pre-clinical licensing deals with pharmaceutical companies. source
Drug discovery use
The company says Taxonomy3-derived targets can inform drug discovery and biomarker identification. source
Genetic analysis
Taxonomy3 uses mathematical analysis of genetic data to identify disease-causing targets. source
Headquarters
Leeds, United Kingdom source
Omics inputs
PatientSeek uses genetics and other omics analyses to stratify patients. source
Partnership contact
The company invites inquiries about strategic collaboration and technology partnership opportunities. source
Patient stratification
PatientSeek is a patient-stratification platform powered by Taxonomy3. source
Product positioning
C4X Discovery describes itself as a drug discovery company focused on small-molecule medicines for immuno-inflammatory diseases. source
Registered office
C4X Discovery lists its registered office in Leeds, United Kingdom. source
Taxonomy3 platform
Taxonomy3 is a target-identification platform based on human genetics. source

Checked against the maker's pages on 14 Nov 2026.